ENTRY       D10982                      Drug
NAME        Rucaparib camsylate (USAN);
            Rubraca (TN)
PRODUCT     RUBRACA (Clovis Oncology)
            RUBRACA (ZR Pharma & GmbH)
FORMULA     C19H18FN3O. C10H16O4S
EXACT_MASS  555.2203
MOL_WEIGHT  555.6608
CLASS       Antineoplastic
             DG02942  PARP inhibitor
REMARK      ATC code: L01XK03
            Chemical structure group: DG01864
            Product (DG01864): D10982<US>
EFFICACY    Antineoplastic, PARP inhibitor
  DISEASE   Ovarian cancer [DS:H00027]
            Ovarian cancer (BRCA-mutated) [DS:H00027]
TARGET      PARP1 [HSA:142] [KO:K24070]
            PARP2 [HSA:10038] [KO:K10798]
            PARP3 [HSA:10039] [KO:K10798]
  PATHWAY   hsa03410(10038+10039+142)  Base excision repair
            hsa04210(10038+10039+142)  Apoptosis
            hsa04217(10038+10039+142)  Necroptosis
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors
                 L01XK03 Rucaparib
                  D10982  Rucaparib camsylate (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Rucaparib
                D10982  Rucaparib camsylate (USAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG02942  PARP inhibitor
               DG01864  Rucaparib
                D10982  Rucaparib camsylate
            Drug classes [BR:br08332]
             Antineoplastic
              DG02942  PARP inhibitor
               D10982  Rucaparib camsylate
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases (EC2)
               Pentosyltransferases
                PARP1
                 D10982  Rucaparib camsylate (USAN) &lt;US&gt;
                PARP2
                 D10982  Rucaparib camsylate (USAN) &lt;US&gt;
                PARP3
                 D10982  Rucaparib camsylate (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10982
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10982
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10982
            Drug groups [BR:br08330]
             Antineoplastic
              DG02942  PARP inhibitor
               DG01864  Rucaparib
DBLINKS     CAS: 1859053-21-6
            PubChem: 342581825
ATOM        39
            1   C1z C    29.4078  -16.7443
            2   C1z C    28.8123  -14.6370
            3   C5x C    30.5461  -17.3107
            4   C1x C    28.1876  -17.3514
            5   C1b C    28.7715  -18.0403
            6   C1y C    29.7522  -15.6060
            7   C1a C    29.3203  -13.2708
            8   C1a C    27.7557  -13.8429
            9   C1x C    31.0132  -16.3299
            10  O5x O    30.9956  -18.6474
            11  C1x C    28.7598  -16.3122
            12  S4a S    27.3938  -18.0462
            13  O1d O    26.7691  -19.2838
            14  O1d O    26.6406  -16.8961
            15  O1d O    28.4271  -19.1786
            16  C8y C    11.0539  -14.7555
            17  C8x C    11.0539  -16.1490
            18  C8y C    12.2384  -16.8457
            19  C8y C    13.4926  -16.1490
            20  C8y C    13.4926  -14.7555
            21  C8x C    12.2384  -14.0587
            22  C8y C    14.8164  -16.5670
            23  C8y C    15.5828  -15.4522
            24  N4x N    14.8164  -14.3374
            25  C8y C    16.9763  -15.4522
            26  C8x C    17.6731  -16.6367
            27  C8x C    19.0665  -16.6367
            28  C8y C    19.7633  -15.4522
            29  C8x C    19.0665  -14.2678
            30  C8x C    17.6731  -14.2678
            31  C1b C    21.1568  -15.4522
            32  N1b N    21.8535  -16.6367
            33  C1a C    23.2470  -16.6367
            34  X   F     9.8695  -14.0587
            35  C1x C    15.4435  -17.8212
            36  C5x C    12.2384  -18.4483
            37  C1x C    14.8164  -19.0753
            38  N1x N    13.4926  -19.3540
            39  O5x O    10.9977  -19.0827
BOND        43
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     1   5 1
            5     2   6 1
            6     2   7 1
            7     2   8 1
            8     3   9 1
            9     3  10 2
            10    4  11 1
            11    5  12 1
            12   12  13 2
            13   12  14 2
            14   12  15 1
            15    6   9 1
            16    6  11 1
            17   16  17 2
            18   17  18 1
            19   18  19 2
            20   19  20 1
            21   20  21 2
            22   16  21 1
            23   19  22 1
            24   22  23 2
            25   23  24 1
            26   20  24 1
            27   23  25 1
            28   25  26 2
            29   26  27 1
            30   27  28 2
            31   28  29 1
            32   29  30 2
            33   25  30 1
            34   28  31 1
            35   31  32 1
            36   32  33 1
            37   16  34 1
            38   22  35 1
            39   35  37 1
            40   36  38 1
            41   37  38 1
            42   36  18 1
            43   36  39 2
///
